Screener
BioCryst Pharmaceuticals BCRX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.54B.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
FAQ
- What is BioCryst Pharmaceuticals's market capitalization?
- BioCryst Pharmaceuticals (BCRX) reported market capitalization of $2.54B in Q2 2026.
- How has BioCryst Pharmaceuticals's market capitalization changed year-over-year?
- BioCryst Pharmaceuticals's market capitalization increased by 22.3% year-over-year, from $2.08B to $2.54B.
- What is the long-term trend for BioCryst Pharmaceuticals's market capitalization?
- Over 5 years (2020 to 2025), BioCryst Pharmaceuticals's market capitalization has grown at a 4.2% compound annual growth rate (CAGR), from $1.34B to $1.64B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about BioCryst Pharmaceuticals's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude